Dotinurad Tablets Market Expected to Grow Significantly with 15.0% CAGR by 2031 | Fuji Yakuhin, Eisai

Market Introduction: -

QY Research has recently published a research report titled, "Global Dotinurad Tablets Market Report, History and Forecast 2025-2031, Breakdown Data by Companies, Key Regions, Types and Application" assessing various factors impacting its trajectory. The global Dotinurad Tablets market report offers a high-quality, accurate, and comprehensive research study to equip players with valuable insights for making strategic business choices. The research analysts have provided deep segmental analysis of the global Dotinurad Tablets market on the basis of type, application, and geography. The vendor landscape is also shed light upon to inform readers about future changes in the market competition. As part of competitive analysis, the report includes detailed company profiling of top players of the global Dotinurad Tablets market. Players can also use the value chain analysis and Porter's Five Forces analysis offered in the report for strengthening their position in the global Dotinurad Tablets market.

The global market for Dotinurad Tablets was estimated to be worth US$ 65.0 million in 2024 and is forecast to a readjusted size of US$ 167 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.

Download Exclusive PDF Sample: (Including Full TOC, Data Tables, Visual Charts) @ https://qyresearch.in/request-sample/pharma-healthcare-dotinurad-tablets-global-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Dotinurad Tablets cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Dotinurad tablets belong to a class of medications known as selective uric acid reabsorption inhibitors.They are primarily prescribed for the treatment of hyperuricemia associated with gout.By blocking URAT1,Dotinurad increases the excretion of uric acid in the urine,thereby lowering blood uric acid levels and reducing the risk of urate crystal formation in joints and tissues.

Dotinurad is a first-in-class Selective Urate Reabsorption Inhibitor (SURI) that lowers serum uric acid levels by selectively inhibiting the URAT1 transporter in the renal proximal tubule, enhancing uric acid excretion. Developed by Eisai, it was first approved in Japan in 2020 and subsequently received marketing authorization in China in December 2024 under the brand name Urelice®. Compared to xanthine oxidase inhibitors like allopurinol and febuxostat, Dotinurad offers a differentiated safety and efficacy profile, particularly in patients with renal dysfunction or intolerance to XOIs. With over 10 million gout patients in China and limited treatment penetration, Dotinurad addresses a significant unmet clinical need. Its novel mechanism, favorable tolerability, and strategic positioning as the first SURI approved in China highlight its strong commercial potential and licensing value in the evolving urate-lowering therapy landscape.

Featured Companies: -

Fuji Yakuhin
Mochida Pharmaceutical
Eisai
Ziska Pharmaceutical
General Pharmaceuticals

Detailed of Dotinurad Tablets Market Segmentation: -

Segmentation By Type :-

0.5mg per Tablet
1.0mg per Tablet
2.0mg per Tablet

Segmentation By Application : -

Hyperuricaemia
Gout
Other

Dotinurad Tablets Market Regional Insights -

United States

-Canada
-Mexico
-Brazil

APAC

-Japan
-South Korea
-China
-ASEAN
-India

EMEA

-Europe
-Middle East
-Africa

Receive the Complete Report with Detailed Insights in 24 Hours (USD 3,200) https://qyresearch.in/buy_checkout/pharma-healthcare-dotinurad-tablets-global-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031/Mzc2MjQ5MA%3D%3D

How Can the Research Study Help your Business?

(1) The information presented in the Dotinurad Tablets report helps your decision makers to become prudent and make the best business choices.

(2) The report enables you to see the future of the global Dotinurad Tablets market and accordingly take decisions that will be in the best interest of your business.

(3) It offers you a forward-looking perspective of the global Dotinurad Tablets market drivers and how you can secure significant market gains in the near future.

(4) It provides SWOT analysis of the global Dotinurad Tablets market along with useful graphics and detailed statistics providing quick information about the market's overall progress throughout the forecast period.

(5) It also assesses the changing competitive dynamics of the global Dotinurad Tablets market using pin-point evaluation.

This Dotinurad Tablets Market Research Report Contains Answers to your following Questions -

(A) Which Manufacturing Technology is Used for Dotinurad Tablets? What Developments Are Going On in That Technology? Which Trends Are Causing These Developments?

(B) Who Are the Global Key Players in This Dotinurad Tablets Market? What's Their Company Profile, Their Product Information, and Contact Information?

(C) What Was Global Market Status of Dotinurad Tablets Market? What Was Capacity, Production Value, Cost and PROFIT of Dotinurad Tablets Market?

(D) What Is Current Market Status of Dotinurad Tablets Industry? What's Market Competition in This Industry, Both Company, and Country Wise? What's Market Analysis of Dotinurad Tablets Market by Taking Applications and Types in Consideration?

(E) What Are Projections of Global Dotinurad Tablets Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?

(F) What Is Dotinurad Tablets Market Chain Analysis by Upstream Raw Materials and Downstream Industry?

(G) What Is Economic Impact On Dotinurad Tablets Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?

(H) What Are Market Dynamics of Dotinurad Tablets Market? What Are Challenges and Opportunities?

(I) What Should Be Entry Strategies, Countermeasures to Economic Impact, Marketing Channels for Dotinurad Tablets Industry?

Why QY Research?

á—’ Established Global Authority: Founded in 2007, QY Research is a globally recognized leader in market intelligence, trusted by over 68,000 clients across 160+ countries.

á—’ Vast Industry Coverage: Offers insights across 3,600+ industries with access to a proprietary database of 2 million+ market reports.

á—’ Partner to Industry Giants: Trusted by 99% of Fortune Global 500 companies and the Top 5 players in most sectors for critical decision-making support.

á—’ Unmatched Expertise: Backed by a global team of 20,000+ domain experts, including seasoned analysts and industry professionals with deep subject knowledge.

á—’ Precision-Driven Methodology: Utilizes a unique 36-role interview verification system and integrates 1,000+ global databases for unmatched data accuracy and reliability.

á—’ Global Intelligence Network: Operates an international data collection system spanning over 160 countries, providing local insights with global relevance.

á—’ Exceptional Client Loyalty: Maintains a 92% repeat client rate, reflecting long-term relationships built on trust, value, and proven outcomes.

á—’ Custom-Tailored Solutions: Offers bespoke research, strategic consulting, and competitive intelligence designed to meet specific business needs-whether for MNCs, SMEs, or startups.

á—’ Proactive Market Insight: Known for identifying trends before they emerge, helping clients anticipate change and shape strategy-not just react to it.

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

This release was published on openPR.